Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
about
Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.The dawn of the liquid biopsy in the fight against cancer.The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer
P2860
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@ast
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@en
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@nl
type
label
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@ast
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@en
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@nl
prefLabel
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@ast
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@en
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@nl
P2860
P356
P1476
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
@en
P2093
Alexandra R Lewis
Juan W Valle
P2860
P304
P356
10.3748/WJG.V22.I32.7175
P407
P50
P577
2016-08-01T00:00:00Z